Ruth Plummer

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Health technology assessment (Winchester, England)

British journal of cancer

Oncoimmunology

Newcastle University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Newcastle University Apr 01 2001

United Kingdom

Clinical Professor

Publications

Victoria Coyle, Caroline Forde, Richard A Adams, Ashley Agus, Rosemary A Barnes, Ian Chau, Michael Clarke, Annmarie Doran, Margaret Grayson, Daniel Francis McAuley, Clíona McDowell, Glenn Phair, Ruth Plummer, Dawn Storey, Anne L Thomas, Richard H Wilson, Ronan McMullan
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT. Health technology assessment (Winchester, England) 28 (14) (2024)
Victoria Coyle, Caroline Forde, Richard A Adams, Ashley Agus, Rosemary A Barnes, Ian Chau, Michael Clarke, Annmarie Doran, Margaret Grayson, Daniel Francis McAuley, Clíona McDowell, Glenn Phair, Ruth Plummer, Dawn Storey, Anne L Thomas, Richard H Wilson, Ronan McMullan
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT. Health technology assessment (Winchester, England) 28 (14) (2024)
Timothy Anthony Yap, Anthony W Tolcher, Ruth Plummer, Jatinder Kaur Mukker, Marta Enderlin, Christine Hicking, Thomas Grombacher, Giuseppe Locatelli, Zoltan Szucs, Ioannis Gounaris, Johann S de Bono
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Timothy Anthony Yap, Anthony W Tolcher, Ruth Plummer, Jatinder Kaur Mukker, Marta Enderlin, Christine Hicking, Thomas Grombacher, Giuseppe Locatelli, Zoltan Szucs, Ioannis Gounaris, Johann S de Bono
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Timothy Anthony Yap, Anthony W Tolcher, Ruth Plummer, Jatinder Kaur Mukker, Marta Enderlin, Christine Hicking, Thomas Grombacher, Giuseppe Locatelli, Zoltan Szucs, Ioannis Gounaris, Johann S de Bono
First-in-Human Study of the Ataxia Telangiectasia and Rad3-related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Timothy Anthony Yap, Anthony W Tolcher, Ruth Plummer, Jatinder Kaur Mukker, Marta Enderlin, Christine Hicking, Thomas Grombacher, Giuseppe Locatelli, Zoltan Szucs, Ioannis Gounaris, Johann S de Bono
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Victoria Coyle, Caroline Forde, Richard A Adams, Ashley Agus, Rosemary A Barnes, Ian Chau, Michael Clarke, Annmarie Doran, Margaret Grayson, Daniel Francis McAuley, Clíona McDowell, Glenn Phair, Ruth Plummer, Dawn Storey, Anne L Thomas, Richard H Wilson, Ronan McMullan
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT. Health technology assessment (Winchester, England) 28 (14) (2024)
Timothy Anthony Yap, Anthony W Tolcher, Ruth Plummer, Jatinder Kaur Mukker, Marta Enderlin, Christine Hicking, Thomas Grombacher, Giuseppe Locatelli, Zoltan Szucs, Ioannis Gounaris, Johann S de Bono
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Melinda A Pruis, Matthew G Krebs, Ruth Plummer, Filip Yves Francine De Vos, Eric Angevin, Hans Prenen, Martin D Forster, Glen Clack, Annegret Van der Aa, Marc Tjwa, Ellen Jansen, Timothy Perera, Martijn Paul Lolkema
A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer. The oncologist (2023)
Ezra Y Rosen, Timothy Anthony Yap, Elizabeth K Lee, Martin Højgaard, Niharika B Mettu, Stéphanie Lheureux, Benedito Arruda Carneiro, Ruth Plummer, Adrian J Fretland, Danielle Ulanet, Yi Xu, Robin McDougall, Maria Koehler, Elisa Fontana
Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related (ATR) Inhibitor Camonsertib. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yvette Drew, Jae-Weon Kim, Richard T Penson, David M O'Malley, Christine Parkinson, Patricia Roxburgh, Ruth Plummer, Seock-Ah Im, Martina Imbimbo, Michelle Ferguson, Ora Rosengarten, Neeltje Steeghs, Min Hwan Kim, Einav Nili Gal-Yam, Daliah Tsoref, Jae-Hoon Kim, Benoit You, Maja J A de Jonge, Roy I Lalisang, Eelke H Gort, Sara Bastian, Kassondra Meyer, Laura Feeney, Nigel Baker, Mei-Lin Ah-See, Susan M Domchek, Susana Banerjee
Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sarah Er Halford, Gareth J Veal, Stephen R Wedge, Geoffrey S Payne, Chris M Bacon, Philip Sloan, Ilaria Dragoni, Kathrin Heinzmann, Sarah Potter, Becky M Salisbury, Maxime Chénard-Poirier, Alastair P Greystoke, Elizabeth C Howell, William A Innes, Karen Morris, Chris Plummer, Mihaela Rata, George Petrides, Hector C Keun, Udai Banerji, Ruth Plummer
A Phase I Dose-Escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sarah Er Halford, Gareth J Veal, Stephen R Wedge, Geoffrey S Payne, Chris M Bacon, Philip Sloan, Ilaria Dragoni, Kathrin Heinzmann, Sarah Potter, Becky M Salisbury, Maxime Chénard-Poirier, Alastair P Greystoke, Elizabeth C Howell, William A Innes, Karen Morris, Chris Plummer, Mihaela Rata, George Petrides, Hector C Keun, Udai Banerji, Ruth Plummer
A Phase I Dose-Escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Juanita Lopez, Julia Lai-Kwon, Rhoda Molife, Liam Welsh, Nina Tunariu, Desamparados Roda, Paula Fernández-García, Victoria Lladó, Adrian G McNicholl, Catalina A Rosselló, Richard J Taylor, Analía Azaro, Jordi Rodon Ahnert, Julieann Sludden, Gareth J Veal, Ruth Plummer, Ander Urruticoechea, Ainhara Lahuerta, Karmele Mujika, Pablo V Escribá
A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma. British journal of cancer (2023)
Robert Jones, Ruth Plummer, Victor Moreno, Louise Carter, Desamparados Roda, Elena Garralda, Rebecca S Kristeleit, Debashis Sarker, Hendrick-Tobias Arkenau, Patricia Roxburgh, Harriet Sarah Walter, Sarah P Blagden, Alan Anthony, Barbara J Klencke, Mark M Kowalski, Udai Banerji
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Melinda L Telli, Sara M Tolaney, Geoffrey I Shapiro, Mark Middleton, Simon R Lord, Hendrik Tobias Arkenau, Andrew N J Tutt, Vandana Abramson, Emma Dean, Tufia C Haddad, Robert Wesolowski, Jordi Ferrer-Playan, Thomas Goddemeier, Thomas Grombacher, Jennifer Dong, Patricia Fleuranceau-Morel, Ivan Diaz-Padilla, Ruth Plummer
Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer. NPJ breast cancer 8 (1) (2022)
Ayumi Hashimoto, Debashis Sarker, Vikash Reebye, Sheba Jarvis, Mikael H Sodergren, Andrew Kossenkov, Emilio Sanseviero, Nina Raulf, Jenni Vasara, Pinelopi Andrikakou, Tim Meyer, Kai-Wen Huang, Ruth Plummer, Cheng Ean Chee, Duncan Spalding, Madhava Pai, Shahid Khan, David J Pinato, Rohini Sharma, Bristi Basu, Daniel Palmer, Yuk-Ting Ma, Jeff Evans, Robert Habib, Anna Martirosyan, Naouel Elasri, Adeline Reynaud, John J Rossi, Mark Cobbold, Nagy A Habib, Dmitry I Gabrilovich
Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (21) (2021)
Hagen Schwenzer, Erica De Zan, Mustafa Elshani, Ruud van Stiphout, Mary Kudsy, Josephine Morris, Valentina Ferrari, In Hwa Um, James Chettle, Farasat Kazmi, Leticia Campo, Alistair Easton, Sebastian Nijman, Michaela Serpi, Stefan N Symeonides, Ruth Plummer, David J Harrison, Gareth Bond, Sarah P Blagden
The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms In Vitro and in a First-In-Human Phase I Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Mark R Middleton, Emma Dean, Thomas R J Evans, Geoffrey I Shapiro, John Pollard, Bart S Hendriks, Martin Falk, Ivan Diaz-Padilla, Ruth Plummer
Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine ± cisplatin in patients with advanced solid tumours. British journal of cancer 125 (4) (2021)
Timothy Anthony Yap, David Shao Peng Tan, Angelika Terbuch, Reece Caldwell, Christina Guo, Boon Cher Goh, Heong Valerie Yue Ming, Noor R Md Haris, Saira Bashir, Yvette Drew, David S Hong, Funda Meric-Bernstam, Gary Wilkinson, Joseph Hreiki, Antje M Wengner, Friedhelm Bladt, Andreas Schlicker, Matthias Ludwig, Yinghui Zhou, Li Liu, Sonal Bordia, Ruth Plummer, Eleni Lagkadinou, Johann S de Bono
First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors. Cancer discovery 11 (1) (2020)
Antoine Hollebecque, Stefania Salvagni, Ruth Plummer, Nicolas Isambert, Patricia Niccoli, Jaume Capdevila, Curigliano Giuseppe, Victor Moreno, Patricia Martin-Romano, Eric Baudin, Marina Arias, Sheila Mora, Juan de Alvaro, Jorge Di Martino, Josep L Parra-Palau, Tania Sánchez-Pérez, Ida Aronchik, Ellen H Filvaroff, Manisha Lamba, Zariana Nikolova, Johann S de Bono
Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)
Poulam M Patel, Christian H Ottensmeier, Clive Mulatero, Paul Lorigan, Ruth Plummer, Hardev Pandha, Somaia Elsheikh, Efthymios Hadjimichael, Naty Villasanti, Sally E Adams, Michelle Cunnell, Rachael L Metheringham, Victoria A Brentville, Lee R Machado, Ian Daniels, Mohamed Gijon, Drew Hannaman, Lindy G Durrant
Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial. Oncoimmunology 7 (6) (2018)

Ruth Plummer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ruth Plummer